Irritable bowel syndrome (IBS) sounds like a catch-all term for “trouble pooping.” And while the condition does involve a range of gastrointestinal issues, IBS symptoms are much broader and can include mental health issues as well. To better understand irritable bowel syndrome, a condition that affects an estimated 12% of people in the U.S. (and women especially—who are two times more likely to have it than men), HG talked with a doctor who answered all our questions about this disorder. While talking about toilet time can be pretty uncomfortable, it us an unavoidable reality for people with IBS.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.
